Clinical Trial Update: Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis [NA]

View source ↗

Summary

One-patient trial update describes the use of tocilizumab in systemic juvenile idiopathic arthritis. The trial was terminated and results were posted in May 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Tufts Medical Center | Conditions: Arthritis, Juvenile Rheumatoid, Still's Disease, Juvenile Onset | NA | Status: TERMINATED | Results posted: 2017-05-15